Prediction of Postoperative Hematoma Occurrence After Ultrasound-guided Vacuum-assisted Breast Biopsy in Minimally Invasive Surgery for Percutaneous Removal of Benign Breast Lesions

Overview

Journal Gland Surg

Publisher AME Publishing Company

Specialty Endocrinology

Date 2020 Nov 23

PMID 33224809

Citations 8

Authors

Jianwei Zheng

Shuyan Cai

Huimin Song

Yunlei Wang

Xiaofeng Han

Gang Han

Haoliang Wu

Zhigang Gao

Affiliations

Soon will be listed here.

Abstract

Background: The exact factors and mechanisms involved in the development of hematoma after breast ultrasound (US)-guided vacuum-assisted biopsy (VAB) are not clear. This study aimed to analyze the occurrence, prognosis, and risk factors of hematoma after US-guided VAB for the removal of benign breast lesions.

Methods: This was a retrospective study of consecutive female patients with breast lesions (BI-RADS 3/4a/4b and confirmed as benign by core needle biopsy) removed by percutaneous excisional biopsy by US-guided VAB at the Beijing Chaoyang Hospital from April 2016 to December 2018. Univariable analyses were conducted to identify the factors associated with hematoma (age, nodule size, laterality, nodule location, number of nodules, BI-RADS classification of ultrasound, pathology, breast shape, menstrual period, efficacy time of bandage, and hemostatic agents). Multivariable analysis was performed to identify the factors independently associated with hematoma.

Results: A total of 293 patients (343 breast lesions) were included. Lesion removal was successful in all cases. Hematomas ≥1 cm were found in 39 patients. Finally, 38 (97.4%) hematomas were absorbed completely within 6 months. The multivariable logistic regression analysis revealed that lesion size (P<0.001; OR: 5.775; 95% CI: 2.752-12.121), number of lesions (P=0.011; OR: 3.205, 95% CI: 1.311-7.834), and the efficacy time of bandage 12-24 h (P=0.003; OR: 5.257, 95% CI: 1.792-15.421) were independently associated with hematoma occurrence after US-guided VAB excision of breast lesions. A lesion size cut-off of 23.4 mm (AUC 0.764, 95% CI: 0.692-0.837; 59.0% sensitivity; 80.3% specificity; 77.5% accuracy; P<0.001) could predict hematoma occurrence.

Conclusions: US-guided excisional VAB can effectively remove benign breast lesions. The factors independently associated with postoperative hematoma are lesion size, lesion number, and effective postoperative compression time of bandage.

Citing Articles

Diagnosis of Benign and Malignant Newly Developed Nodules on the Surgical Side After Breast Cancer Surgery Based on Machine Learning.

Wang Z, Li Q, Wang Y, Qian L, Hu X, Liu D Breast J. 2025; 2025:8511049.

PMID: 39996101 PMC: 11850066. DOI: 10.1155/tbj/8511049.

A retrospective comparative study on the diagnostic efficacy and the complications: between CassiII rotational core biopsy and core needle biopsy.

Xie S, Ju S, Zhang X, Qi C, Zhang J, Mao M Front Oncol. 2023; 13:1067246.

PMID: 37823052 PMC: 10562690. DOI: 10.3389/fonc.2023.1067246.

Vascular Complications following Vacuum-Assisted Breast Biopsy (VABB): A Case Report and Review of the Literature.

Pansa E, Guzzardi G, Santocono S, Carriero A Tomography. 2023; 9(4):1246-1253.

PMID: 37489467 PMC: 10366872. DOI: 10.3390/tomography9040099.

Implementation of vacuum-assisted excision as a management option for benign and high-risk breast lesions.

van de Voort E, Struik G, Birnie E, Sinke R, Verver D, van Streun S Br J Radiol. 2023; 96(1147):20220776.

PMID: 37171394 PMC: 10321268. DOI: 10.1259/bjr.20220776.

Efficacy and safety of percutaneous ultrasound-guided vacuum-assisted excision for the treatment of clinical benign breast lesions larger than 3 cm: a retrospective cohort study.

Wang B, Jiang Y, Zhang M, Li S, Niu R, Liu G Ann Transl Med. 2023; 10(24):1345.

PMID: 36660716 PMC: 9843416. DOI: 10.21037/atm-22-5829.

References

Ko K, Jung H, Youk J, Lee K . Potential application of ultrasound-guided vacuum-assisted excision (US-VAE) for well-selected intraductal papillomas of the breast: single-institutional experiences. Ann Surg Oncol. 2011; 19(3):908-13. DOI: 10.1245/s10434-011-2050-3. View

Luo H, Chen X, Tu G, Wang J, Wu C, Yang G . Therapeutic application of ultrasound-guided 8-gauge Mammotome system in presumed benign breast lesions. Breast J. 2011; 17(5):490-7. DOI: 10.1111/j.1524-4741.2011.01125.x. View

Order B, Schaefer P, Peters G, Eckmann-Scholz C, Hilpert F, Strauss A . Evaluation of two different vacuum-assisted breast biopsy systems: Mammotome(R) system 11G/8G vs. ATEC(R) system 12G/9G. Acta Radiol. 2013; 54(2):137-43. DOI: 10.1258/ar.2012.120420. View

Vargas H, Vargas M, Gonzalez K, Burla M, Khalkhali I . Percutaneous excisional biopsy of palpable breast masses under ultrasound visualization. Breast J. 2006; 12(5 Suppl 2):S218-22. DOI: 10.1111/j.1075-122X.2006.00325.x. View

Tokumoto M, Kashiwagi S, Ishihara S, Asano Y, Sakimura C, Kurata K . [Clinical experience with a handheld vacuum-assisted biopsy system (VACORA® )for mammary lesions]. Gan To Kagaku Ryoho. 2015; 41(12):1887-9. View

Hawley J, Lawther H, Erdal B, Yildiz V, Carkaci S . Outcomes of benign breast papillomas diagnosed at image-guided vacuum-assisted core needle biopsy. Clin Imaging. 2015; 39(4):576-81. DOI: 10.1016/j.clinimag.2015.01.017. View

Seely J, Verma R, Kielar A, Smyth K, Hack K, Taljaard M . Benign Papillomas of the Breast Diagnosed on Large-Gauge Vacuum Biopsy compared with 14 Gauge Core Needle Biopsy - Do they require surgical excision?. Breast J. 2016; 23(2):146-153. DOI: 10.1111/tbj.12702. View

Papathemelis T, Heim S, Lux M, Erhardt I, Scharl A, Scharl S . Minimally Invasive Breast Fibroadenoma Excision Using an Ultrasound-Guided Vacuum-Assisted Biopsy Device. Geburtshilfe Frauenheilkd. 2017; 77(2):176-181. PMC: 5357216. DOI: 10.1055/s-0043-100387. View

Pearlman M, Griffin J . Benign breast disease. Obstet Gynecol. 2010; 116(3):747-758. DOI: 10.1097/AOG.0b013e3181ee9fc7. View

10.

Mosier A, Keylock J, Smith D . Benign papillomas diagnosed on large-gauge vacuum-assisted core needle biopsy which span <1.5 cm do not need surgical excision. Breast J. 2013; 19(6):611-7. DOI: 10.1111/tbj.12180. View

11.

Debi U, Thulkar S, Sharma S, Sharma M, Seenu V, Deo S . Role of directional vacuum assisted breast biopsy in previously equivocal biopsies for breast masses suspicious for malignancy. Malays J Pathol. 2015; 37(1):25-33. View

12.

Grady I, Gorsuch H, Wilburn-Bailey S . Long-term outcome of benign fibroadenomas treated by ultrasound-guided percutaneous excision. Breast J. 2008; 14(3):275-8. DOI: 10.1111/j.1524-4741.2008.00574.x. View

13.

Chen S, Yang H, Hwang T, Chen M, Cheung Y, Hsueh S . Intraoperative ultrasonographically guided excisional biopsy or vacuum-assisted core needle biopsy for nonpalpable breast lesions. Ann Surg. 2003; 238(5):738-42. PMC: 1356153. DOI: 10.1097/01.sla.0000094439.93918.31. View

14.

Yao F, Li J, Wan Y, Zhong Y, Wei W, Tu Y . Sonographically guided vacuum-assisted breast biopsy for complete excision of presumed benign breast lesions. J Ultrasound Med. 2012; 31(12):1951-7. DOI: 10.7863/jum.2012.31.12.1951. View

15.

Jiang Y, Lan H, Ye Q, Jin K, Zhu M, Hu X . Mammotome biopsy system for the resection of breast lesions: Clinical experience in two high-volume teaching hospitals. Exp Ther Med. 2013; 6(3):759-764. PMC: 3786805. DOI: 10.3892/etm.2013.1191. View